Genmab presents positive EPCORE FL-1 subgroup data for lymphoma treatment
Go back to Genmab presents positive EPCORE FL-1 subgroup data for lymphoma treatment| (NASDAQ: GMAB) | Delayed: 25.27 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.27 | 52 Week High | $ | |||
| Open | $25.27 | 52 Week Low | $ | |||
| Day High | $25.27 | P/E | N/A | |||
| Day Low | $25.27 | EPS | $ | |||
| Volume | 3,174 | |||||
